Showing 112 of 112on this page. Filters & sort apply to loaded results; URL updates for sharing.112 of 112 on this page
CytoDyn to Present on Leronlimab Induction of PD-L1 and
CytoDyn Receives Clearance from Brazil’s ANVISA to Commence Phase 3 ...
FDA Grants CytoDyn Fast Track Designation for Leronlimab
CytoDyn Announces Leadership Transition Plan to Support Regulatory ...
CytoDyn Begins Phase 3 Trial Of Antibody Treatment For Critically Ill ...
FDA Puts CytoDyn Clinical Trials For HIV, COVID-19 On Hold | the deep dive
CytoDyn provides updates on leronlimab for the treatment of HIV and ...
CytoDyn withdraws HIV approval application for leronlimab
CytoDyn Starts Phase 3 Trial Of Antibody Treatment For COVID-19 ...
Cytodyn total assets 2025| Statista
CytoDyn to seek regulatory approval for Covid-19 drug Vyrologix
CytoDyn Closes $17.5M Financing to Fund Continued Development of ...
Former Cytodyn Execs Charged With Fraud For Misrepresenting HIV, COVID ...
CytoDyn announces submission of revised HIV clinical trial protocol to ...
Healthcare Roundup - CytoDyn to supply leronlimab to UK COVID-19 ...
CytoDyn Releases Mechanism-of-Action Animation for Leronlimab in Immuno ...
CytoDyn Treats First Patient with Leronlimab in Phase 2 Trial for GvHD ...
CytoDyn Inc (OTCMKTS: CYDY) Biotech behind Leronlimab for HIV / NASH ...
CytoDyn (CYDY) leronlimab for COVID-19 coronavirus treatment. NEXT ...
CytoDyn to assess leronlimab in Phase II NASH trial
U.K. MHRA Clears CytoDyn to File its BLA for Leronlimab as One ...
CytoDyn Inc files Phase 2 protocol with FDA for use of leronlimab and ...
CytoDyn files for expanded access use of leronlimab for multi-drug ...
CytoDyn files new protocol with FDA for four doses of leronlimab for ...
Vancouver-based CytoDyn makes waves in breast cancer treatment - The ...
CytoDyn wins IRB approval to give leronlimab to triple-negative breast ...
CytoDyn Files FDA-Suggested Modifications to IND and Protocol for Phase ...
CytoDyn Announces Stunning Results from Clinical Trials Evaluating ...
CytoDyn Leronlimab - YouTube
CytoDyn Yanks BLA Submission for Leronlimab in HIV, Blames CRO - BioSpace
2020-04-02 Treatment With CytoDyn S Leronlimab Indicates ...
CytoDyn Profile | The Scientist
CytoDyn Inc - CytoDyn’s clinical trial results thus far indicate that ...
CytoDyn Inc.: CytoDyn Announces First Patient Dosed in Expanded Access ...
CytoDyn wins first buy order from Chiral Pharma for using leronlimab ...
Vancouver’s CytoDyn intends to file to market HIV drug - The Columbian
CytoDyn doses subjects in long-haulers Covid-19 therapeutic trial
Vancouver-based CytoDyn on the verge of leronlimab cancer trial | The ...
Embattled CytoDyn Sets New Course Toward NASH, Tough Tumors - BioSpace
Awareness campaign Leronlimab by the Giants at CytoDyn - YouTube
Why CytoDyn (OTC:CYDY) Is Launching an Expanded Access Program for ...
We plan on manufacturing as much as we can: CytoDyn CEO on COVID-19 ...
CytoDyn HIV Justification Report: Guidance From FDA
Cytodyn and Leronlimab
CytoDyn makes waves in breast cancer care - Camas-Washougal Post-Record
Chiral Pharma, Cytodyn Inc., partners to secure COVID-19 drug FDA ...
A Penny Stock To Watch In Challenging Cancer Space - CytoDyn (OTC:CYDY ...
Long-suffering CytoDyn withdraws HIV approval application for ...
CytoDyn Announces Preliminary Results from 30 mTNBC Patients Treated ...
CytoDyn Reveals New Leronlimab Data for mTNBC at AACR
CytoDyn Bags FDA Nod for Phase II Trial of Leronlimab in Colorectal Cancer
FDA Torpedoes CytoDyn Leronlimab for COVID-19 with Rare Public Scolding ...
CytoDyn (CYDY) NEXT SUPER STOCK livestream 5/13/20. Leronlimab COVID-19 ...
Another CCR5 pathway - potential for Leronlimab in diabetis - CYTODYN ...
CytoDyn Stock: Moving Leronlimab Forward On All Fronts (CYDY) : r/CYDY
Cytodyn Inc. (CYDY) Message Board | InvestorsHub
CytoDyn (OTC: CYDY) Receives IRB Approval To Proceed With Compassionate ...
CytoDyn received first order from Chiral Pharma for use of Leronlimab ...
FDA lifts two-year clinical hold on CytoDyn’s HIV trial ...
Leronlimab (350 mg) Weekly Use for 14 Weeks in Open Label Arm of NASH ...
EX-99.1
Exhibit 99.2
CytoDyn's chief scientific officer Rahman quietly exits amid leronlimab ...
Slide 10
Leronlimab Biosimilar - Anti-CCR5 Antibody (A323539)
Frontiers | CCR5 Receptor Occupancy Analysis Reveals Increased ...
CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood ...
Anti-CCR5(leronlimab biosimilar) mAb
CytoDyn's Breast Cancer Breakthrough: A Catalyst-Driven Growth Story ...
Cytodyn’s Leronlimab Could Be an Answer to COVID-19
Two Additional Coronavirus Patients Treated at Leading New York ...
(Leronlimab) - 药物靶点：CCR5_在研适应症：非酒精性脂肪性肝炎，实体瘤，胶质母细胞瘤_专利_临床_研发
靶向CCR5治疗三阴性乳腺癌(TNBC)！CytoDyn新型单抗leronlimab在美申请突破性药物资格(BTD)！ - FDA信息专区 - 生物谷
醫療保健精選——CytoDyn的leronlimab治療新冠患者的實驗取得成功，Novavax將展示COVID-19疫苗數據 | NAI 500
米CytoDyn社、トリプルネガティブ乳がんに抗CCR5抗体の拡大アクセスプログラムを立ち上げ：日経バイオテクONLINE
CytoDyn’s Leronlimab Featured on OneNews in Philippines on May 9 - YouTube
Dr. Lalezari on leronlimab's mechanism of action for solid tumors ...
Charlie Sheen shows interest in CytoDyn, which just raised $33M to ...
医疗保健精选——CytoDyn提交leronlimab的营销申请，武田提交Cabometyx的补充申请 | NAI 500
Filling the Gaps in Antagonist CCR5 Binding, a Retrospective and ...
靶向CCR5治疗新型冠状病毒肺炎(COVID-19)！CytoDyn新型单抗leronlimab申请开展II期临床试验！ - FDA信息专区 ...
Suppression of human and simian immunodeficiency virus replication with ...
CytoDyn公司 Leronlimab與卡鉑聯用獲FDA快速通道-環球生技月刊
COVID-19: AGC, manufacturing contract from CytoDyn: US FDA, ‘Leronlimab ...
Single-molecule and super-resolved imaging deciphers membrane behavior ...
CYTODYN, LERONLIMAB Probability on Success: 90% : LeronLimab_Times
In harms way | CytoDyn, Leronlimab, & Long COVID | clinical trial ...
CytoDyn, Inc. (OTC: CYDY) Leronlimab Potential Treatment for Coronavirus.
CCL5 mediates breast cancer metastasis and prognosis through CCR5/Treg ...
Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy ...
CYTODYN, LERONLIMAB Probability on Success: 90% : r/LeronLimab_Times
New Additions To The Leadership Team : r/LeronLimab_Times
IJMS | Free Full-Text | Neuroinflammation: A Potential Risk for ...
Licensing deals rack up in 2021 - oncology - potential for a research ...
CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic ...
IJMS | Free Full-Text | Naming the Barriers between Anti-CCR5 Therapy ...
Cydy-leronlimab gemala
CytoDyn’s Promotion Of Investigational Drug Leronlimab Once Again ...
Vancouver company hopes new drug can help people fight COVID-19 ...
Severely Ill COVID-19 patient at Southern California medical center ...
HIV Drug Leronlimab, Which Successfully Treats Coronavirus, Moving To ...
5 Marijuana Stocks To Own In 2020 and Why - MJ Global Report
.jpg?VersionId=8ZWXljs1vg9MSVhs4w1w3DZ45jnBBFuA)
